Journal article
EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy.
- Giovanella L Clinic for Nuclear Medicine and Thyroid Competence Center, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Via Ospedale 6, CH-6500, Bellinzona, Switzerland. Luca.Giovanella@eoc.ch.
- Avram AM Division of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, MI, USA.
- Iakovou I Department of Nuclear Medicine, Papageorgiou Hospital, Aristotle University, Thessaloniki, Greece.
- Kwak J Division of Nuclear Medicine, Department of Radiology, University of Colorado, Denver, CO, USA.
- Lawson SA Division of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, MI, USA.
- Lulaj E Division of Nuclear Medicine, Department of Radiology, Johns Hopkins Medical Institute, Baltimore, MD, USA.
- Luster M Clinic for Nuclear Medicine, Marburg University Hospital, Marburg, Germany.
- Piccardo A Nuclear Medicine Unit, Imaging Department, Ente Ospedaliero Ospedali Galliera, Genoa, Italy.
- Schmidt M Clinic for Nuclear Medicine, Cologne University Hospital, Cologne, Germany.
- Tulchinsky M Division of Nuclear Medicine, Department of Radiology, Penn State University, Hershey, PA, USA.
- Verburg FA Clinic for Nuclear Medicine, Marburg University Hospital, Marburg, Germany.
- Wolin E Division of Nuclear Medicine, Department of Radiology, David Grant Medical Center, Vacaville, CA, USA.
- 2019-08-09
Published in:
- European journal of nuclear medicine and molecular imaging. - 2019
99mTc-sestaMIBI, 18F-fluorodeoxyglucose
Radioiodine uptake test
Scintigraphy
Thyroid
Biological Transport
Europe
Fluorodeoxyglucose F18
Humans
Iodine Radioisotopes
Nuclear Medicine
Positron Emission Tomography Computed Tomography
Practice Guidelines as Topic
Radionuclide Imaging
Societies, Medical
Thyroid Gland
English
INTRODUCTION
Scintigraphic evaluation of the thyroid gland enables determination of the iodine-123 iodide or the 99mTc-pertechnetate uptake and distribution and remains the most accurate method for the diagnosis and quantification of thyroid autonomy and the detection of ectopic thyroid tissue. In addition, thyroid scintigraphy and radioiodine uptake test are useful to discriminate hyperthyroidism from destructive thyrotoxicosis and iodine-induced hyperthyroidism, respectively.
METHODS
Several radiopharmaceuticals are available to help in differentiating benign from malignant cytologically indeterminate thyroid nodules and for supporting clinical decision-making. This joint practice guideline/procedure standard from the European Association of Nuclear Medicine (EANM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) provides recommendations based on the available evidence in the literature.
CONCLUSION
The purpose of this practice guideline/procedure standard is to assist imaging specialists and clinicians in recommending, performing, and interpreting the results of thyroid scintigraphy (including positron emission tomography) with various radiopharmaceuticals and radioiodine uptake test in patients with different thyroid diseases.
Scintigraphic evaluation of the thyroid gland enables determination of the iodine-123 iodide or the 99mTc-pertechnetate uptake and distribution and remains the most accurate method for the diagnosis and quantification of thyroid autonomy and the detection of ectopic thyroid tissue. In addition, thyroid scintigraphy and radioiodine uptake test are useful to discriminate hyperthyroidism from destructive thyrotoxicosis and iodine-induced hyperthyroidism, respectively.
METHODS
Several radiopharmaceuticals are available to help in differentiating benign from malignant cytologically indeterminate thyroid nodules and for supporting clinical decision-making. This joint practice guideline/procedure standard from the European Association of Nuclear Medicine (EANM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) provides recommendations based on the available evidence in the literature.
CONCLUSION
The purpose of this practice guideline/procedure standard is to assist imaging specialists and clinicians in recommending, performing, and interpreting the results of thyroid scintigraphy (including positron emission tomography) with various radiopharmaceuticals and radioiodine uptake test in patients with different thyroid diseases.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1007/s00259-019-04472-8
- PMID 31392371
- Persistent URL
- https://sonar.ch/global/documents/248837
Statistics
Document views: 102
File downloads: